📌 Key Takeaways
- Topic: What Is the Mohs Hardness of Silica and Quartz? Hardness Values Explained
- Keywords: what is silica
- Published: 2026-11-20 10:55:58
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
BET Surface Area of Silica: Measurement Method and Typical Values by Grade
- Silica for Printing Ink: Functions, Grades and Formulation Tips
- Wu, L. et al. Cell Membrane-camouflaged Multi-functional Dendritic Big Pore Mesoporous Silica Nanoparticles for Combined Photothermal Therapy and Radiotherapy of Cancer. Chem. Res. Chin. Univ. 38, 562-571 (2022). Piece CAS Google Scholar
- Fumed Silica 200 m²/g: Properties, Typical Uses and Comparable Grades
- The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
- Silica Testing Methods: How to Test Purity, Particle Size, BET and Moisture
- Silica Surface Area Explained: Typical BET Values by Type and Why It Matters
- Wang, Y. et al. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy. Coll. Surf. B Biointerfac. 212, 112357 (2022). Article CAS Google Scholar
What Is a Silane Coupling Agent? How It Works and How to Choose One for Silica
What is silica (SiO₂)?
mesoporous silica
What is the difference between fumed silica and precipitated silica?
fused silica vs quartz These authors contributed equally: Bolong Xu, Shanshan Li
What drives silica raw material prices?
MSNs are gradually being developed as promising drug delivery carriers due to their brilliant biocompatibility, biodegradability, and greatly ordered pore structure. Owing to the great flexibility in tuning the surface properties of MSNs, specific surface functionalization modification of MSNs can achieve precise modulation of drug delivery behavior, thus to meet the application requirements. Currently, the most researched is the construction of stimuli-responsive MSNs-based drug delivery system (Fig. 6c ), i.e., when MSNs reach the lesion site, the release of drugs is controllably stimulated by specific internal or external components, thus achieving the improved drug utilization and staying away from drug leakage at non-lesion sites. 259, 272, 331 The most core step in this process is connecting some caps with stimulus-responsive properties onto the MSNs surface, which can be called gatekeepers, 119, 158 nanovalves, 332, 333 or others. Once the therapeutic drug is filled into the mesopore of MSNs, the pore entrances are blocked by the caps to prevent the drug from diffusing out. Under normal physiological conditions, the caps always keep the pores in a closed state, but when reaching to the lesion, the caps are separated under the stimulation of certain components, which in turn induces targeted on-demand release of drugs. These caps can be polymers, 334 metal/metal compound NPs, 170, 335 biomolecules, 336 etc. While exogenous stimuli such as light, ultrasound, magnetic field and electric field, endogenous stimuli such as temperature, pH, redox agents, and enzymes, can activate the caps. Several examples about the surface modification of MSNs and the corresponding stimuli-responsive plans are briefly clarified here.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.